Signs Point To Abbott Joint Venture With India’s Biocon
This article was originally published in The Tan Sheet
India-based Biocon’s collaborative research arm Syngene, known for its research partnerships with a large set of global companies, likely will develop products up to a certain stage based on leads Abbott provides. Industry sources say they expect Abbott and Biocon are in advanced discussions.
You may also be interested in...
Okla. and Ala. limit PSE sales while Colo. and Hawaii consider NPLEx; Abbott, Biocon team on Indian nutrition R&D; Bunge leaves Solae stake to DuPont; Valeant buys AcneFree; more news In Brief.
Sanofi’s search for high-growth consumer brands in India led to the firm’s Aug. 24 acquisition of Universal Medicare Pvt. Ltd.’s nutraceutical business.
FDA releases drug patch guidance